Аденома околощитовидной железы у молодой женщины с хронической болезнью почек: первичный или третичный гиперпаратиреоз?

1. Iacobone M, Carnaille B, Palazzo FF, Vriens M. Hereditary hyperparathyroidism - a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck Arch Surg. 2015;400:867-86. doi: 10.1007/s00423-015-1342-7
2. Мамедова Е.О., Мокрышева Н.Г., Рожинская Л.Я. Особенности первичного гиперпаратиреоза у пациентов молодого возраста. Проблемы эндокринологии. 2018;64(3):163-9 [Mamedova EO, Mokrysheva NG, Rozhinskaya LYa. Characteristics of primary hyperparathyroidism in young patients. Problemi endokrinolgii. 2018;64(3):163-9 (In Russ.)]. doi: 10.14341/probl9399
3. Ветчинникова О.Н., Денисова Л.Б., Гаганов Л.Е. Трудности дифференциальной диагностики тяжелого гиперпаратиреоза, выявленного на стадии терминальной почечной недостаточности (Клиническое наблюдение). Нефрология и диализ. 2015;17(1):78-88 [Vetchinnnkova ON, Denisova LB, Gaganov LE. Difficulties in differentiation for the diagnosis of severe hyperparathyroidism at the stage end-stage renal failure (Clinical observation). ­Nefrologiya i dializ. 2015;17(1):78-88 (In Russ.)].
4. Grube M, Bech JN, Pedersen EB. Primary hyperparathyroidism as a cause of chronic renal failure. Ugeskr Laeger. 2012;174(8):502-3.
5. Jimbo-Saito R, Ubara Y, Kadoguchi H, et al. A case of primary hyperparathyroidism with severe bone and renal changes. J Bone Miner Metab. 2009;27(6):727-32. doi: 10.1007/s00774-009-0053-y
6. Ruggeri RM, Calamoneri E, Russo A, et al. Supra-acetabular brown tumor due to primary hyperparathyroidism associated with chronic renal failure. Sci World J. 2010;4(10):799-805. doi: 10.1100/tsw.2010.86
7. Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression and therapeutic options. Clin J Am Soc Nephrol. 2011;6:913-21. doi: 10.2215/CJN.06040710
8. Jamal SA, Miller PD. Secondary and Tertiary Hyperparathyroidism. J Clin Densitometry. 2013;16(1):64-8. doi: 10.1016/j.jocd.2012.11.012
9. Błazejewska A, Flisiński M, Pypkowski J, Manitius J. Patient with chronic kidney disease and primary or tertiary hyperparathyroidism – case report. Pol Merkur Lekarski. 2009;27(162):484-7.
10. Нефрология. Клинические рекомендации. Под ред. Е.М. Шилова, А.В. Смирнова, Н.Л. Козловской. М.: ГЭОТАР-Медиа, 2016; с. 687-709 [Nephrology. Clinical guidelines. Ed. EM Shilova, AV Smirnova, NL Kozlovskaya. Moscow: GEOTAR-Media; 2016; p. 687-709 (In Russ.)].
11. Tanaka R, Kakuta T, Koiwa F, et al. Long-term prognosis of parathyroid function in chronic dialysis patients after PEIT – a single-centre trial. Nephrol Dial Transplant Plus. 2008;1(Suppl. 3):iii29-iii34. doi: 10.1093/ndtplus/sfn084
12. Matsushita H. Different responses between the upper and the lower parathyroid gland in a state of secondary hyperfunction. A study on chronic renal failure by morphometry and nuclear DNA analysis. Virchows Arch A Pathol Anat Histopathol. 1989;414(4):331-7. doi: 0.1007/BF00734088
13. Dusilova Sulkova S, Horacek J, Zivny P, et al. Primary hyperparathyroidism associated with hypocalcemia in a patient presenting with kidney disease. Int Urol Nephrol. 2010;42(3):835-9. doi: 10.1007/s11255-010-9743-6
14. Silverberg SJ, Lewiecki EM, Mosekilde L, et al. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94:351-65. doi: 10.1210/jc.2008-1760
15. Phelps KR, Stote KS, Mason D. Tubular calcium reabsorption and other aspects of calcium homeostasis in primary and secondary hyperparathyroidism. Clin Nephrol. 2014;82(2):83-91. doi: 10.5414/CN108223
16. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132:359-72.
17. Lunn MR, Mendoza JM, Pasche LJ, et al. Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary? Nephrol Dial Transplant Plus. 2010;3:366-71. doi: 10.1093/ndtplus/sfq077
18. Skandarajah A, Barlier A, Morlet-Barlat N, et al. Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age? World J Surg. 2010;34(6):1294-8. doi: 10.1007/s00268-009-0388-5
19. Giusti F, Cavalli L, Cavalli T, Brandi ML. Hereditary hyperparathyroidism syndromes. J Clin Densitom. 2013;16(1):69-74. doi: 10.1016/j.jocd.
2012.11.003
20. DeLellis RA. Parathyroid tumors and related disorders. Modern Pathology. 2011;24(2):78-93. doi: 10.1038/modpathol.2010.132
21. Rosai J, DeLellis RA, Carcangiu MA, et al. Tumours of the thyroid and parathyroid glands. AFIP Atlas of tumor pathology. Series 4. Maryland. Silver Spring. 2014;579-80.
22. Dochez V, Ducarme G. Primary hyperparathyroidism during pregnancy. Arch Gynecol Obstet. 2015;291:259-63. doi: 10.1007/s00404-014-3526-8
23. Kim SM, Choi HJ, Lee JP, et al. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease. J Renal Nutr. 2014;24(10):20-5. doi: 10.1053/j.jrn.2013.07.003
24. Scillitani A, Guarnieri V, De Geronimo S, et al. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endoctinol Metab. 2004;89:5634-8. doi: 10.1210/jc.2004-0129
25. Wang W, Li C, Kwon T-H. Reduce expression of renal Na+ transporterin rats with PTH-induced hypercalcemia. Am J Physiol Renal Physiol. 2004;286:534-45. doi:10.1152/ajprenal.00044.2003

________________________________________________

1. Iacobone M, Carnaille B, Palazzo FF, Vriens M. Hereditary hyperparathyroidism - a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck Arch Surg. 2015;400:867-86. doi: 10.1007/s00423-015-1342-7
2. Mamedova EO, Mokrysheva NG, Rozhinskaya LYa. Characteristics of primary hyperparathyroidism in young patients. Problemi endokrinolgii. 2018;64(3):163-9 (In Russ.) doi: 10.14341/probl9399
3. Vetchinnnkova ON, Denisova LB, Gaganov LE. Difficulties in differentiation for the diagnosis of severe hyperparathyroidism at the stage end-stage renal failure (Clinical observation). ­Nefrologiya i dializ. 2015;17(1):78-88 (In Russ.)
4. Grube M, Bech JN, Pedersen EB. Primary hyperparathyroidism as a cause of chronic renal failure. Ugeskr Laeger. 2012;174(8):502-3.
5. Jimbo-Saito R, Ubara Y, Kadoguchi H, et al. A case of primary hyperparathyroidism with severe bone and renal changes. J Bone Miner Metab. 2009;27(6):727-32. doi: 10.1007/s00774-009-0053-y
6. Ruggeri RM, Calamoneri E, Russo A, et al. Supra-acetabular brown tumor due to primary hyperparathyroidism associated with chronic renal failure. Sci World J. 2010;4(10):799-805. doi: 10.1100/tsw.2010.86
7. Cunningham J, Locatelli F, Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression and therapeutic options. Clin J Am Soc Nephrol. 2011;6:913-21. doi: 10.2215/CJN.06040710
8. Jamal SA, Miller PD. Secondary and Tertiary Hyperparathyroidism. J Clin Densitometry. 2013;16(1):64-8. doi: 10.1016/j.jocd.2012.11.012
9. Błazejewska A, Flisiński M, Pypkowski J, Manitius J. Patient with chronic kidney disease and primary or tertiary hyperparathyroidism – case report. Pol Merkur Lekarski. 2009;27(162):484-7.
10. Nephrology. Clinical guidelines. Ed. EM Shilova, AV Smirnova, NL Kozlovskaya. Moscow: GEOTAR-Media; 2016; p. 687-709 (In Russ.)
11. Tanaka R, Kakuta T, Koiwa F, et al. Long-term prognosis of parathyroid function in chronic dialysis patients after PEIT – a single-centre trial. Nephrol Dial Transplant Plus. 2008;1(Suppl. 3):iii29-iii34. doi: 10.1093/ndtplus/sfn084
12. Matsushita H. Different responses between the upper and the lower parathyroid gland in a state of secondary hyperfunction. A study on chronic renal failure by morphometry and nuclear DNA analysis. Virchows Arch A Pathol Anat Histopathol. 1989;414(4):331-7. doi: 0.1007/BF00734088
13. Dusilova Sulkova S, Horacek J, Zivny P, et al. Primary hyperparathyroidism associated with hypocalcemia in a patient presenting with kidney disease. Int Urol Nephrol. 2010;42(3):835-9. doi: 10.1007/s11255-010-9743-6
14. Silverberg SJ, Lewiecki EM, Mosekilde L, et al. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab. 2009;94:351-65. doi: 10.1210/jc.2008-1760
15. Phelps KR, Stote KS, Mason D. Tubular calcium reabsorption and other aspects of calcium homeostasis in primary and secondary hyperparathyroidism. Clin Nephrol. 2014;82(2):83-91. doi: 10.5414/CN108223
16. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005;132:359-72.
17. Lunn MR, Mendoza JM, Pasche LJ, et al. Hyperparathyroidism with hypercalcaemia in chronic kidney disease: primary or tertiary? Nephrol Dial Transplant Plus. 2010;3:366-71. doi: 10.1093/ndtplus/sfq077
18. Skandarajah A, Barlier A, Morlet-Barlat N, et al. Should routine analysis of the MEN1 gene be performed in all patients with primary hyperparathyroidism under 40 years of age? World J Surg. 2010;34(6):1294-8. doi: 10.1007/s00268-009-0388-5
19. Giusti F, Cavalli L, Cavalli T, Brandi ML. Hereditary hyperparathyroidism syndromes. J Clin Densitom. 2013;16(1):69-74. doi: 10.1016/j.jocd.
2012.11.003
20. DeLellis RA. Parathyroid tumors and related disorders. Modern Pathology. 2011;24(2):78-93. doi: 10.1038/modpathol.2010.132
21. Rosai J, DeLellis RA, Carcangiu MA, et al. Tumours of the thyroid and parathyroid glands. AFIP Atlas of tumor pathology. Series 4. Maryland. Silver Spring. 2014;579-80.
22. Dochez V, Ducarme G. Primary hyperparathyroidism during pregnancy. Arch Gynecol Obstet. 2015;291:259-63. doi: 10.1007/s00404-014-3526-8
23. Kim SM, Choi HJ, Lee JP, et al. Prevalence of vitamin D deficiency and effects of supplementation with cholecalciferol in patients with chronic kidney disease. J Renal Nutr. 2014;24(10):20-5. doi: 10.1053/j.jrn.2013.07.003
24. Scillitani A, Guarnieri V, De Geronimo S, et al. Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor. J Clin Endoctinol Metab. 2004;89:5634-8. doi: 10.1210/jc.2004-0129
25. Wang W, Li C, Kwon T-H. Reduce expression of renal Na+ transporterin rats with PTH-induced hypercalcemia. Am J Physiol Renal Physiol. 2004;286:534-45. doi:10.1152/ajprenal.00044.2003

О.Н. Ветчинникова1, Е.И. Прокопенко1, И.А. Воронкова1,2

1 ГБУЗ МО «Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского», Москва, Россия;
2 ФГБУ «Национальный медицинский исследовательский центр эндокринологии» Минздрава России, Москва, Россия

________________________________________________

O.N. Vetchinnikova1, E.I. Prokopenko1, I.A. Voronkova1,2

1 Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia;
2 Endocrinology Research Centre, Moscow, Russia